Aronow, H. D., Califf, R. M., Harrington, R. A., Vallee, M., Graffagnino, C., Shuaib, A., … Topol, E. J. (2003). Higher aspirin dose is associated with reduced mortality and more serious bleeding in patients with recent cerebrovascular or coronary ischemic events: Insights from the BRAVO trial. In CIRCULATION (Vol. 108, pp. 680–681). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS.

Aronow, H. D., R. M. Califf, R. A. Harrington, M. Vallee, C. Graffagnino, A. Shuaib, D. Fitzgerald, et al. “Higher aspirin dose is associated with reduced mortality and more serious bleeding in patients with recent cerebrovascular or coronary ischemic events: Insights from the BRAVO trial.” In CIRCULATION, 108:680–81. LIPPINCOTT WILLIAMS & WILKINS, 2003.

Aronow HD, Califf RM, Harrington RA, Vallee M, Graffagnino C, Shuaib A, et al. Higher aspirin dose is associated with reduced mortality and more serious bleeding in patients with recent cerebrovascular or coronary ischemic events: Insights from the BRAVO trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 680–1.

Aronow, H. D., et al. “Higher aspirin dose is associated with reduced mortality and more serious bleeding in patients with recent cerebrovascular or coronary ischemic events: Insights from the BRAVO trial.” CIRCULATION, vol. 108, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2003, pp. 680–81.

Aronow HD, Califf RM, Harrington RA, Vallee M, Graffagnino C, Shuaib A, Fitzgerald D, Easton JD, Van de Werf F, Diener HC, Ferguson J, Koudstaal P, Amarenco P, Theroux P, Davis S, Topol EJ. Higher aspirin dose is associated with reduced mortality and more serious bleeding in patients with recent cerebrovascular or coronary ischemic events: Insights from the BRAVO trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 680–681.